Chemotherapy: The more, the better in malignant lymphoma?

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 40, Issue , 1997, Pages

  Tobinai, K ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Autologous hematopoietic stem cell transplantation; Dose intensity; Granulocyte colony stimulating factor; High dose chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISOLONE; VINCRISTINE;

CONFERENCE PAPER; DOSE RESPONSE; HIGH RISK POPULATION; HODGKIN DISEASE; HUMAN; LYMPHOMA; PRIORITY JOURNAL; RELAPSE; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

EID: 0030834133     PISSN: 09439404     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051072     Document Type: Conference Paper

References (25)

1. Armitage JO (1989) Bone marrow transplantation in the treatment of patients with lymphoma. Blood 73:1749
2. Bierman PJ, Vose JM, Armitage JO (1994) Autologous transplantation for Hodgkin's disease: coming of age? Blood 83:1161
3. Cooper IA, Wolf MM, Robertson TI, Fox RM, Matthews JP, Stone JM, Ding JC, Dart G, Matthews J, Firklin FC, Lowenthal RM, Ironside P for the Australian and New Zealand Lymphoma Group (1994) Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. J Clin Oncol 12:769
4. DeVita VT Jr, Serpick AA, Carbone PP (1970) Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73:881
5. Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA Jr, Miller TP (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328:1002
6. Frei E III, Antman K, Teicher B, Eder P, Schnipper L (1989) Bone marrow autotransplantation for solid tumors: prospect. J Clin Oncol 7:515
7. Gianni AM, Bregni M, Siena S, Brambilla C, Di Nicola M, Lombardi F, Gandora L, Tarella C, Pileri A, Stern A, Valagussa P, Bonadonna G (1996) Is high-dose better than standard-dose chemotherapy as initial treatment of poor-risk large-cell lymphomas?: A critical analysis from available randomized trials. Ann Oncol 7[Suppl 3]:12
8. Gisselbrecht C, Lepage E, Morel P, Lederlin P, Coiffier B, Tilly H, Bosly A, Gabarre J, Briere J, Fillet G, Molina T, Reyes F, for the GELA (1996) Short and intensified treatment with autologous stem-cell transplantation versus ACVB regimen in poor prognosis aggressive lymphoma: prognostic factors of induction failure. Ann Oncol 7[Suppl 3]:18
9. Goldie JH, Coldman AJ (1979) A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63:1727
10. Gordon LI, Harrington D, Andersen J, Colgan J, Glick J, Neiman R, Mann R, Resnick GD, Barcos M, Gottlieb A, O'Connell M (1992) Comparison of a second-generation combination chemotherapeutic regimon (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med 327:1342
11. Haioun C, Lepage E, Gisselbrecht C, Coiffier B, Bosly A, Tilly H, Morel P, Nouvel C, Herbrecht R, D'Agay MF, Gaulard P, Reyes F for the Groupe d'Etude des Lymphomes de l'Adulte (1994) Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. J Clin Oncol 12:2543
12. Haioun C, Lepage E, Gisselbrec(Latin small letter h with stroke)t C, Coiffier B, Bosly A, Dupriez B, Nouvel C, Tilly H, Lederlin P, Biron P, Briere J, Gaulard P, Reyes F (1996) Autologous bone marrow transplantation versus sequential chemotherapy for aggressive non-Hodgkin's lymphoma in first complete remission: a study of 541 patients (LNH87-2 protocol). Ann Oncol 7[Suppl 3]:24
13. International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987
14. Kwak LW, Halpern J, Olshen RA, Horning SJ (1990) Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis. J Clin Oncol 8:963
15. Lee R, Cabanillas F, Bodey GP, Freireich EJ (1986) A 10-year update of CHOP-bleo in the treatment of diffuse large cell lymphoma. J Clin Oncol 4:1445
16. Linch DC, Winfield D, Goldstone AH, Moir D, Hancock B McMillan A, Chopra R, Milligan D, Vaughan Hudson G (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomized trial. Lancet 341:1051
17. McKelvey EM, Gottlieb JA, Wilson HE, Haut A, Talley RW, Stephens R, Lane M, Gamble JF, Jones SE, Grozea PN, Gutterman J, Coltman C Jr, Moon TE (1976) Hydroxydaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38:1484
18. Non-Hodgkin's Lymphoma Pathologic Classification Project (1982) National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and descriptions of a Working Formulation for clinical usage. Cancer 49:2112
19. Ohtsu T, Wakita H, Igarashi T, Itoh K, Fujii H, Sasaki Y (1996) A phase I-II study of dose-escalating CHOP with or without G-CSF for aggressive non-Hodgkin's lymphoma. Ann Oncol 7[Suppl 3]:59
20. Philip T, Armitage JO, Spitzer G, Chauvin F, Jagannath S, Cahn J-Y, Colombat P, Goldstone AH, Gorin NC, Flesh M, Laporte J-P, Maraninchi D, Pico J, Bosly A, Anderson C, Scots R, Biron P, Cabanillas F, Dicke K (1987) High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 316:1493
21. Philip T, Gugulielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, Sonnenveld P, Gisselbrecht C, Cahn J-Y, Harousseau J-L, Coiffier B, Biron P, Mandelli F, Chauvin F (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540
22. Shimoyama M, Ota K, Kikuchi M, Yunoki K, Konda S, Takatsuki K, Ichimaru M, Ogawa M, Kimura I, Tominaga S, Tsugane S, Taguchi H, Minato K, Takenaka T, Tobinai K, Kurita S, Oyama A, Hisano S, Kozuru M, Matsumoto M, Nomura K, Takiguchl T, Sugai S, Yamaguchi K, Hattori T, Kinoshita K, Tajima K, Suemasu K, for the Lymphoma Study Group (1988) Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M. J Clin Oncol 6:128
23. Shimoyama M, Ota K, Kikuchi M, Yunoki K, Konda S, Takatsuki K, Ichimaru M, Tominaga S, Tsugane S, Minato K, Tobinai K, Oyama A, Hisano S, Matsumoto M, Takiguchi T, Yamaguchi K, Kinoshita K, Tajima K, Suemasu K for the Lymphoma Study Group (1988) Major prognostic factors of adult patients with advanced T cell lymphoma/leukemia. J Clin Oncol 6:1088
24. Tobinai K, Shimoyama M, Minato K, Shirakawa S, Hotta T, Fukuhara S, Suzuki H, Ichimaru M, Sai T, Konda S, Mikuni K, Toki H, Kozuru M, Deura K, Takatsuki K, for the JCOG-Lymphoma Study Group (1994) Japan Clinical Oncology Group (JCOG) phase II trial of second-generation "LSG4 Protocol" in aggressive lymphoma including ATL: prognostic factors and a predictive model. Proc Am Soc Clin Oncol 14:378 (abstract)
25. Verdonck LF, Putten WLJ van, Hagenbeek A, Schouten HC, Sonnenveld P, Imhoff GW van, Kluin-Nelemans HC, Raemaekers JMM, Oers RHJ van, Haak HL, Schots R, Dekker AW, Gast GC de, Loewenberg B (1995) Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med 332:1045